Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BIO-TECHNE Corp TECH

Technology Scientific & Technical Instruments
Bio-Techne Corporation is a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities. The Company's products assist scientific investigations into biological processes and the nature and progress of specific diseases. The Company, in partnership with Wilson Wolf, is creating products such as media and cytokines that are... see more

Recent & Breaking News (NDAQ:TECH)

BIO-TECHNE DECLARES DIVIDEND

PR Newswire August 4, 2022

BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN

PR Newswire August 4, 2022

BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS

PR Newswire August 4, 2022

BIO-TECHNE ANNOUNCES LICENSING AGREEMENT AND PARTNERSHIP WITH UNIVERSITY OF DUNDEE

PR Newswire July 28, 2022

BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS

PR Newswire July 14, 2022

BIO-TECHNE LAUNCHES NEW TURBO CE-SDS(TM) CARTRIDGE, ACCELERATING PROTEIN PURITY ANALYSIS THROUGHPUT BY 400%

PR Newswire July 12, 2022

Bio-Techne Announces Launch of the CE-IVD RNAscope(TM) ISH Probe High Risk HPV Assay for Head and Neck Cancer

PR Newswire July 6, 2022

BIO-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION

PR Newswire July 5, 2022

BIO-TECHNE TO ACQUIRE NAMOCELL

PR Newswire June 22, 2022

Bio-Techne Celebrates 40,000 Unique RNAscope(TM) in situ Hybridization Probes, Targeting Any Gene, Any Tissue, Any Species.

PR Newswire May 26, 2022

GLOBAL STUDY DEMONSTRATES ICE3 AND MAURICE CAPILLARY ISOELECTRIC FOCUSING COMPARABILITY IN THE JOURNAL OF ELECTROPHERESIS

PR Newswire May 25, 2022

BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE

PR Newswire May 19, 2022

Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria® Bladder Cancer Test

PR Newswire May 12, 2022

BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS

PR Newswire May 10, 2022

BIO-TECHNE DECLARES DIVIDEND

PR Newswire May 4, 2022

BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS

PR Newswire May 4, 2022

BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE

PR Newswire May 2, 2022

BIO-TECHNE INCLUDED ON THE FORBES BEST EMPLOYERS FOR DIVERSITY 2022 LIST

PR Newswire April 26, 2022

BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS

PR Newswire April 13, 2022

BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF MARAVAI LIFESCIENCES, INTRODUCE NEW SIMPLE PLEX HEK 293 HCP 3G IMMUNOASSAY

PR Newswire April 12, 2022